Is INAB or INMB more undervalued in 2026?

CirclFi compares IN8bio, Inc. (INAB) and INmune Bio Inc. (INMB) using 13 institutional-grade valuation models. INAB has a Quality of Company score of 3.2/10 while INMB scores 5.8/10.

Which is a better buy — INAB or INMB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do INAB and INMB valuations compare?

INAB at $1.87 and INMB at $1.41 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

INAB vs INMB Valuation Comparison 2026 — Intrinsic Value Analysis

INAB

Biological Products, (No Diagnostic Substances)

IN8bio, Inc.

Quality

3.2

out of 10

Value Trap

LOW

Price

$1.87

Last close

Models

7/13

Active

INMB

Biological Products, (No Diagnostic Substances)

INmune Bio Inc.

Quality

5.8

out of 10

Value Trap

LOW

Price

$1.41

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	INAB Fair Value	INAB Upside	INMB Fair Value	INMB Upside
Bayesian DCF	Intrinsic	$1.54	-17.5%	$0.56	-60.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$3.60	+92.5%	$1.90	+35.0%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for INAB vs INMB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

INAB vs INMB — Which Stock Is More Undervalued?

INMB scores higher with a 5.8/10 quality rating vs INAB's 3.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing IN8bio, Inc. (INAB) and INmune Bio Inc. (INMB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

INAB currently trades at $1.87 with a QOC of 3.2/10, while INMB trades at $1.41 with a QOC of 5.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).